Company intelligence / Profile preview
Beker Laboratories
- Ownership
- Private
- Employees
- ~750
- Development stage
- Other
Overview
Beker Laboratories has developed a broad portfolio of generic pharmaceuticals, including notable products such as a generic version of Sovaldi® for Hepatitis C. Clinical results from observational studies show efficacy and safety in real-world use for their branded generics like Trombix® and Sofosdac®. The company focuses on quality local production to meet international standards.[3][4]
- Therapeutic areas
- CardiovascularInfectious Diseases
- Modalities
- Small molecules (generics in tablet, capsule, powder form)[4][6]
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Beker Laboratories.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beker Laboratories.